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ABSTRACT In North America there are two generally
recognized pathotypes (pathotypes 1 and 2) of the fungus
Entomophaga grylli which show host-preferential infection of
grasshopper subfamilies. Pathotype 3, discovered in Austra-
lia, has a broader grasshopper host range and was considered
to be a good biocontrol agent. Between 1989 and 1991 patho-
type 3 was introduced at two field sites in North Dakota. Since
resting spores are morphologically indistinguishable among
pathotypes, we used pathotype-specific DNA probes to con-
firm pathotype identification in E. grylli-infected grasshop-
pers collected at the release sites in 1992, 1993, and 1994. In
1992, up to 23% of E. grylli-infected grasshoppers of the
subfamilies Melanoplinae, Oedipodinae, and Gomphocerinae
were infected by pathotype 3, with no infections >1 km from
the release sites. In 1993, pathotype 3 infections declined to
1.7%. In 1994 grasshopper populations were low and no
pathotype 3 infections were found. The frequency of pathotype
3 infection has declined to levels where its long-term survival
in North America is questionable. Analyses of biocontrol
releases are critical to evaluating the environmental risks
associated with these ecological manipulations, and molecular
probes are powerful tools for monitoring biocontrol releases.
Current widely publicized problems with synthetic chemical
insecticides have given rise to a sense of urgency in the
development of biological control agents as supplements or
alternatives to these chemicals. Chemical control is not only
often environmentally harsh but also at times ineffective; in
1987 chemical pesticides failed to control an outbreak of
grasshoppers in the western United States. The application of
non-native strains of entomopathogenic fungi offers tremen-
dous potential in pest control but also demands a careful and
responsible approach. There is a perception that non-native
strains may behave very differently from native strains. One
particular example that has aroused controversy is the release
of an Australian pathotype of the entomopathogenic fungus
Entomophaga grylli into the United States for the control of
grasshopper populations (1-3). The perceived benefits of
introducing foreign insect pathogens into the United States (3)
has potential risks which include inhibition of natural pathogen
effectiveness, possible threat to nontargeted organisms, loss of
biological diversity, and disruption of food chains (1, 2).
There are three generally recognized pathotypes of E. grylli,
all apparently specific pathogens of grasshoppers but with
different grasshopper subfamily host ranges (4). The major
pest grasshopper species in North America occur in the
subfamilies Melanoplinae and Gomphocerinae, with localized
outbreaks of Oedipodinae. Pathotypes 1 and 2 are endemic to
North America and show preferential infection of different
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grasshopper subfamilies; under laboratory and field conditions
pathotype 1 preferentially infects oedipodine grasshoppers
whereas pathotype 2 infects melanopline grasshoppers. Patho-
type 3, although isolated from a cyrtacanthacridine grasshop-
per in Australia (Praxibulus sp.), has a broader host range
which includes North American oedipodine and melanopline
grasshoppers under laboratory conditions (5). Its ability to
infect North American gomphocerine grasshoppers was not
known. Pathotype 3 was considered to be a good candidate as
a grasshopper biological control agent because it held the
potential to infect melanopline and oedipodine grasshoppers
and, possibly, gomphocerine grasshoppers (3).
As part of a biological control trial to suppress rangeland
grasshopper populations, pathotype 3 was introduced into
McKenzie County, North Dakota, from 1989 to 1991 (6). The
lack of basic information on the establishment, spread, host
range, and epidemiology of the Australian pathotype (1, 2, 7)
resulted in a decision to discontinue grasshopper control trials
with exotic organisms (7). The inability to distinguish the
Australian pathotype from endemic North American E. grylli
pathotypes precluded a testable prediction of its effects on
grasshopper populations and nontarget insects. Grasshoppers
infected by E. grylli typically exhibit "summit disease syn-
drome," characterized by their clinging to elevated surfaces,
such as stalks of wheat, prior to death (6). However, no
morphological characters (resting spores, conidia, hyphal bod-
ies) are adequate for separating the three pathotypes (8-10).
In retrospect, we constructed cloned DNA fragments as
pathotype-specific probes (11) to allow positive identification
of the three E. grylli pathotypes at two release sites and
surrounding areas during the three years (1992-1994) follow-
ing the release of pathotype 3.
MATERIALS AND METHODS
Release of Pathotype 3-Infected Grasshoppers. Grasshop-
pers (Melanoplus differentialis) were injected with pathotype 3
protoplasts and released at two sites (A and B), 17 km apart,
in McKenzie County, North Dakota, from 1989 to 1991 (12).
Sites A and B are also known as Wold's field and Nelson's field
no. 1, respectively. Site Awas a mixed alfalfa stand whereas site
B was primarily composed of crested wheatgrass. The number
of pathotype 3-infected grasshoppers released each year at
each site was as follows: site A, 500 grasshoppers in 1989, 2500
in 1990, 0 in 1991; site B, 0 grasshoppers in 1989 and 1990, 2000
in 1991. In the following years (1992, 1993, and 1994), dead
grasshoppers that contained resting spores or conidia were
collected near the release sites and areas concentric to the
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FIG. 1. Frequency of pathotype 1, 2, or 3 infections, as determined
by probe analysis, in E. grylli-infected grasshoppers collected within 1
km of sites A and B in 1992 and 1993. The sums may be greater than
100% due to coinfections. No pathotype 3 infections were found in
1994.
release sites (12) and analyzed for E. grylli infection by using
the pathotype-specific probes.
Construction of Pathotype-Specific DNA Probes. The con-
struction ofE. grylli pathotype-specific clonedDNA probes has
been reported (11).
Fracturing of Resting Spores and Extraction of DNA. To
extract DNA from resting spores in dead grasshoppers the
infected grasshopper was placed in 0.5 ml of 10mM Tris/1 mM
EDTA buffer (pH 7.5) in a 2.2-ml Eppendorf tube. Nymphal
grasshoppers were homogenized whole, whereas the abdo-
mens of adult grasshoppers were homogenized. Each sample
was homogenized (Tissue Tearor, model 985-370, variable
speed, setting 5, 30,000 rpm; Biospec Products, Inc.) on ice
three times for 10 sec with a 5-sec interval between pulses.
DNA was extracted twice with an equal volume of phenol/
chloroform and precipitated with 0.1 volume of 3 M sodium
acetate and 1 volume of 2-propanol. The mixture was centri-
fuged and the pellet was washed with ice-cold 70% ethanol.
The DNA pellet was resuspended in 100,ul of Tris/EDTA (pH
7.5) buffer. DNA was denatured with 40 .lI of 1 M NaOH and
incubated for 10 min at room temperature. Then 170 ,ul of
0.125 NaOH/0.125X standard saline citrate was added for a
final volume of 310 Al. DNA (100 ,ul) was blotted onto
nitrocellulose membranes in triplicate and each membrane was
hybridized with a radiolabeled pathotype-specific DNA probe.
Bioassay of Pathotype 3 in Field-Collected Grasshoppers.
Fifth-instar grasshoppers were collected for bioassay from
McKenzie County, North Dakota, and surrounding areas in
1989-1991. Field-collected grasshoppers were housed in cages
and fed wheat bran for 10 days prior to bioassay. Twenty-five
grasshoppers in each of 12 species collected were injected with
104 protoplasts in 10 lI of Grace's insect tissue culture medium
(12). Grasshoppers were checked daily for mortality. Dead
grasshoppers were placed on water agar and checked for
conidia formation within 24 hr of death. They were also
dissected to determine whether resting spores were present in
the body cavity.
RESULTS
Of the 1216 E. grylli-infected grasshoppers (888 within 1 km of
sites A and B and 243 concentric to the release sites) that were
collected in 1992-1994 and analyzed, 1127 (92.7% of total)
showed positive signals for one of the three pathotypes. Fig. 1
shows the percent infection by each of the three E. grylli
pathotypes, as determined by probe hybridization analysis,
within 1 km of sites A and B in 1992 and 1993. Pathotype 3 had
overwintered through to 1992 and in that year 23.0% (site A)
and 22.5% (site B) of all E. grylli-infected grasshoppers were
infected by pathotype 3. In 1993, pathotype 3 infection de-
creased -95% compared to 1992, with 0.6% (site A) and 1.7%
(site B) infection.
In 1994 grasshopper populations were low and only 75 E.
grylli-infected grasshoppers were collected, with 71 grasshop-
pers testing positive for pathotype 2. None of the grasshoppers
collected in 1994 tested positive for pathotype 1 or 3. These
data are not shown since the sample size was small.
Outside the 1-km radius from the release sites, 243 grass-
hoppers were collected (141 in 1992 and 102 in 1993) that gave
positive signals (99.6% of total) by probe analysis for patho-
type 1 or 2 but not for pathotype 3, indicating that pathotype
3 probably did not disperse from the release sites.
Table 1 shows the breakdown of single-pathotype infections
by grasshopper subfamily and site in 1992 and 1993. Site A had
a greater proportion of melanopline grasshoppers, while site B
had more oedipodine grasshoppers. Frequency differences for
pathotypes 1 and 2 at sites A and B (Fig. 1) reflect different
species compositions and subfamily representations at the two
sites (Table 1). Pathotype 1 preferentially infected oedipodine
grasshoppers and pathotype 2 preferentially infected melano-
pline grasshoppers. However, pathotypes 1 and 2 showed
1.1-15.8% cross-infection from their preferred hosts, and
pathotype 3 infected melanopline, oedipodine, and gompho-
cerine grasshoppers. In 1992, the frequency of pathotype 3
infection was highest in the Gomphocerinae at siteA and in the
Melanoplinae at site B.
Analysis of the dot blots revealed infection by more than one
pathotype in individual grasshoppers (Table 2). In 1992, 9.0%
(site A) and 15.5% (site B) of all E. grylli-infected grasshoppers
showed coinfection of pathotype 3 with pathotype 1 or 2. The
frequency of pathotype 3 with pathotype 1 or 2 coinfection was
highest in the Gomphocerinae. Only one incident of a coin-
fection of pathotype 1 with pathotype 2 was observed, and that
was in an oedipodine grasshopper at site B in 1992.
Table 1. Percent infection by E. grylli pathotypes at sites A and B in 1992 and 1993 by grasshopper subfamily
Site A Site B
1992 1993 1992 1993
Pathotype Pathotype Pathotype Pathotype
Grasshopper subfamily n 1 2 3 n 1 2 3 n 1 2 3 n 1 2 3
Melanoplinae 153 2.0 78.3 12.5 113 3.5 95.6 0 39 15.8 57.9 18.4 54 5.7 94.3 0
Oedipodinae 44 65.9 11.4 11.4 36 91.7 8.3 0 139 74.1 2.9 5.0 179 96.6 1.1 2.3
Gomphocerinae 26 23.0 34.6 26.9 8 75.0 25.0 0 10 70.0 10.0 0 12 100.0 0 0
Values in 1992 may not equal 100%, due to coinfections (see Table 2). n is the sample size.
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Table 2. Percent coinfection by E. grylli pathotypes (1 + 2, 1 + 3, or 2 + 3) at sites A and B in
1992 by grasshopper subfamily
Site A Site B
Grasshopper subfamily 1 + 2 1 + 3 2 + 3 1 + 2 1 + 3 2 + 3
Melanoplinae 0 0.7 6.5 0 2.6 5.3
Oedipodinae 0 9.1 2.3 0.7 17.3 0
Gomphocerinae 0 11.5 3.9 0 20.0 0
No coinfections were observed in 1993. Sample sizes are as in Table 1.
Combining the single-pathotype infections with the coin-
fections, pathotype 3 infections were represented equally well
(19.6-22.3%) in all three grasshopper subfamilies in 1992. The
exception was that 42.3% (26.9% pathotype 3 infection plus
11.5% and 3.9% pathotype 3 coinfections) of the gomphocer-
ine grasshoppers at site A in 1992 were infected by pathotype
3. However, the relative number of E. grylli-infected gompho-
cerine grasshoppers was low.
Table 3 shows the occurrence of E. grylli pathotypes in the
infected grasshopper species collected at sites A and B in 1992
and 1993. The three most common E. grylli-infected grasshop-
per species were Melanoplus sanguinipes, Melanoplus bivittatus,
and Camnula pellucida. This table also shows host preferences
by the pathotypes in grasshopper species. Pathotype 2 infected
the oedipodine grasshopper Metatorpardalinus; however, only
two of these grasshoppers were collected. All other grasshop-
per species were preferentially infected by their respective
pathotypes, although higher levels of pathotype 3 infections
were noted in Melanoplus femurrubrum and Ageneotettix deo-
rum in certain instances. We have also shown that, along with
melanopline grasshoppers, gomphocerine grasshoppers were
preferentially infected by pathotype 1. No E. grylli-infected
Hesperotettix viridis were found at the field release sites, and
only one H. viridis was collected at these sites between 1989 and
1994. Sites A and B were without snakeweed, a food plant for
H. viridis. For laboratory bioassay, H. viridis was collected at a
field that contained snakeweed.
Table 4 shows the results of the laboratory bioassays of
pathotype 3 in field-collected grasshoppers. Pathotype 3
caused mycosis in melanopline, oedipodine, and gomphocer-
ine grasshoppers under laboratory conditions. The grasshop-
per species host range of pathotype 3 in laboratory bioassays
was broader than that of infection of grasshopper species by
this pathotype found in the field. Laboratory infections by
pathotype 3 were observed in M. differentialis, M. confusus, and
Aeropedellus clavatus, but field infections by pathotype 3 in
these grasshoppers were not found. Phoetaliotes nebrascensis,
Spharagemon collare, M. pardalinus, and Chorthippus curtipen-
nis were not represented in the laboratory bioassay and
pathotype 3-infected cadavers were not found in the field. H.
viridis was not infected by pathotype 3 in the laboratory
bioassay, nor were pathotype 3-infected cadavers found at the
two field sites.
DISCUSSION
We have utilized pathotype-specific probes for the ento-
mopathogenic fungus E. grylli (11) in order to monitor the
establishment of an Australian pathotype 3 introduced into
North Dakota between 1989 and 1991. Our results suggest that
pathotype 3 caused substantial infection (-23% of E. grylli-
infected grasshoppers) in 1992, but in 1993 infection declined
to <2% and no pathotype 3 infections were found in 1994.
Molecular markers have previously been used to identify an
exotic entomopathogenic fungus in North America (13). En-
tomophaga maimaiga, an Asian fungus, was identified as the
causative agent for gypsy moth epizootics in eastern North
America, and the geographical range of this fungus is increas-
ing (13). These studies show that molecular probes are pow-
erful tools for epizootiological studies involving biocontrol
agents.
Table 3. Infection occurrence of E. grylli pathotypes in grasshopper species and frequency of E.
grylli-infected grasshoppers at sites A and B in 1992 or 1993
Grasshopper Pathotype* Grasshopper
subfamily Species 1 2 3 frequencyt
Melanoplinae Melanoplus sanguinipes x 0 x H
Melanoplus bivittatus x 0 x H
Melanoplus packardii x 0 x M
Melanoplus infantilis x 0 x L
Melanoplus gladstoni x 0 L
Melanoplus femurrubruml 0 0 L
Melanoplus differentialis 0 L
Melanoplus confusus 0 L
Phoetaliotes nebrascensis 0 L
Oedipodinae Camnula pellucida 0 x x H
Spharagemon collare 0 L
Metator pardalinus 0 L
Gomphocerinae Ageneotettix deorum§ 0 x 0 M
Aulocara ellioti 0 x x M
Aeropedellus clavatus 0 L
Chorthippus curtipennis 0 L
*x indicates the occurrence of a pathotype infection in a grasshopper species. 0 indicates that >60% of
the individuals in the species were infected by that pathotype in 1992 or 1993.
tA measure of E. grylli-infected grasshopper frequency; H, high (>100 E. grylli-infected grasshoppers
collected); M, medium (<100 but >20); L, low (<20).
tSites A and B, 1992, >60% pathotype 3 but at site B, 1993, >60% pathotype 2.
§Site A, 1992, >60% pathotype 3 but at site B, >60% pathotype 1.
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Table 4. Results of laboratory bioassay of pathotype 3 in
field-collected grasshoppers
Grasshopper Pathotype 3
subfamily Species infection
Melanoplinae Melanoplus sanguinipes +
Melanoplus bivittatus +
Melanoplus packardii +
Melanoplus infantilis +
Melanoplus femurrubrum +
Melanoplus differentialis +
Melanoplus confusus +
Phoetaliotes nebrascensis +
Hesperotettix viridis
Oedipodinae Camnula pellucida +
Gomphocerinae Ageneotettix deorum +
Aulocara ellioti +
Twenty-five fifth-instar grasshoppers were bioassayed for each
species. Assessment of infection: +, >70% of grasshoppers died from
pathotype 3 infection 5-10 days after injection of protoplasts; -,
<10% of grasshoppers died but no mycosis was found.
The ecological principles implicated in the possible failure of
pathotype 3 to establish in North. America have been outlined
by Lockwood (1); these include competitive exclusion, invasion
ecology, and community resistance to perturbation. The dif-
ferential susceptibility among grasshopper species to E. grylli
infections and any changes in the species mixes may affect the
frequency of occurrence of pathotype 3. Grasshopper species
densities and the phenology of occurrence, in addition to their
ratios, could play a role in pathotype-specific infections of
grasshoppers from the field. Migrant grasshoppers infected by
pathotype 1 or 2 would further dilute the effects of pathotype
3. Despite optimistic arguments for the establishment of exotic
biological control agents of grasshoppers in North America
(3), the relative frequency of pathotype 3 has declined to levels
so low that its maintenance in North Dakota may be difficult
without more releases. Even if pathotype 3 resting spores are
able to persist in soils and through winters in North Dakota,
its future impact on suppression of grasshopper populations to
a greater extent than pathotypes 1 and 2 would probably be
minimal since biological control that is based on a rare species
is likely to be ineffective (14).
Coinfections of pathotype 1 or 2 with pathotype 3 were
observed. The technique we employed cannot distinguish
between an infection by a recombinant strain from an infection
derived by two separate pathotypes. The formation of stable
recombinant strains could have an adverse impact on the
viability and continuation of native pathotypes, the loss of
which could severely affect the prairie ecosystem (1, 2).
However, E. grylli resting spores are formed by azygosporo-
genesis (15) with no apparent sexual recombination, preclud-
ing the possibility of recombinant strains. Pathotypes 1 and 2
appear to be separated with respect to host coinfection since
there was only one incident of coinfection by these pathotypes.
Host-specific cuticular cues, phenology of infection, and com-
petitive exclusion are some of the factors that may be respon-
sible for separating pathotype 1 from pathotype 2 in host
grasshoppers. As expected, pathotypes 1 and 2 showed host
preferences for oedipodine and melanopline grasshoppers,
respectively, but host switching was detected in nature. We also
showed that, in the field, gomphocerine grasshoppers were
preferentially infected by pathotype 1.
Lockwood (1, 2) expressed concern that pathotype 3 may
infect "beneficial" grasshoppers or suppress certain grasshop-
per species, resulting in the disruption of the local prairie
ecosystem. M. femurrubrum is an intermediate host of a
parasite of several native bird species, and suppression of this
grasshopper species on a large scale could have ecological
impacts (1). In 1992, half of the E. grylli-infected M. femur-
rubrum were infected by pathotype 3. This could represent
some ground for concern if large populations of this grass-
hopper were present. However, only 12 E. grylli-infected M.
femurrubrum were collected. No E. grylli-infected H. viridis
were found in the field. This grasshopper is viewed as a
beneficial species because it feeds on a noxious weed,
snakeweed (1, 7). Snakeweed was not common at either site
and the H. viridis that were bioassayed in the laboratory were
collected "10 km from the field release sites. Under labora-
tory conditions, this grasshopper was the only species tested
that was not infected by pathotype 3. The host range of
pathotype 3 was broader in the laboratory (physiological host
range) than in the field (ecological host range). Physiological
and ecological host ranges of entomopathogenic fungi may
differ, and caution should be exercised when extrapolating
laboratory bioassay results to potential infections in the field.
In light of the controversy surrounding the introduction of
the exotic strain, the failure of pathotype 3 to establish in 1993
and 1994 after a relatively high infection in 1992 is one of the
best possible outcomes in this biological control trial. Persis-
tence of pathotype 3 could result in ecological disruption of the
prairie community (1, 2). However, previous to its decline,
epizootics caused by pathotype 3 in 1992 may be, in part,
responsible for the recent decrease in grasshopper populations
(16), and in 1994 only 75 E. grylli-infected grasshoppers were
collected near the sampling sites. Pathotype 3 may have helped
to cause a reduction in the local grasshopper populations in
1992 and thus eliminate susceptible hosts. Mainly targeted,
economically important grasshoppers were affected and no
catastrophic effects on the natural community have been
noted.
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